This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Anxiety disorders
  • /
  • Guidelines for the pharmacological treatment of an...
Guideline

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

Read time: 1 mins
Last updated:5th Jan 2012

Objective: Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners.

Methods: This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies.

Results: First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy.

Conclusions: This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.

 

Read full guideline